The serum progranulin concentration is elevated in CLL patients with an advanced stage of disease [94,148,163,164,165] and is an independent predictor of disease progression and overall survival in CLL [84,94,165] (Table 1). This evidence concerns the gene GRN and B-cell chronic lymphocytic leukemia.